Fig. 1From: Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary reportMyocardial glucose uptake (MGU). A Data are mean ± SEM; B FDG PET/CT images during euglycemic hyperinsulinemic clamp of two representative cases: fused and 3D maximum intensity projection anterior views pre- and post-placebo and pre- and post-dapagliflozin, respectivelyBack to article page